BSX Operating Cash Flow Growth
Boston Scientific · Operating Cash Flow Growth
BSX Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported5.69%period ending
BSX TTM Cash from Operations YoY % (54.82% → 5.69%)
Year-over-year change
High-resolution chart · PNG
BSX operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 5.6943% | |
| 13.8772% | |
| 31.9942% | |
| 57.5613% | |
| 62.804% | |
| 53.8958% | |
| 37.2353% | |
| 24.7769% | |
| 23.8006% | |
| 39.628% | |
| 64.0236% | |
| 96.5748% | |
| 78.5055% | |
| 16.0995% | |
| -18.3957% | |
| -42.0339% | |
| -46.9015% | |
| -18.2451% | |
| 24.0053% | |
| 35.2325% | |
| 61.8326% | |
| 32.6473% | |
| -17.8649% | |
| 31.2984% | |
| 19.2771% | |
| 201.7131% | |
| 492.2581% | |
| 0% | |
| 4.3088% | |
| -74.2558% | |
| -80.7931% | |
| -3.7252% | |
| 53.6552% | |
| 113.6631% | |
| 66.0494% | |
| 44.6707% | |
| -43.0926% | |
| -7.0099% | |
| 62% | |
| 17.4402% | |
| 96.302% | |
| 4.4622% | |
| -52.7187% | |
| -35.4809% | |
| -35.5511% | |
| -21.8945% | |
| 14.5307% | |
| -8.4718% | |
| -17.7959% | |
| -9.3927% | |
| -12.0635% | |
| -2.9032% | |
| -8.1709% | |
| -6.2263% | |
| 25% | |
| 11.9134% | |
| 116.5584% | |
| 157.2266% | |
| 210.1538% | |
| 344.5916% | |
| 292.3567% | |
| 76.5517% | |
| -61.0778% | |
| -137.1921% | |
| -88.5569% | |
| -76.0528% | |
| -31.3322% | |
| -17.1429% | |
| 5.0536% | |
| -3.8125% | |
| 30.1927% | |
| 48.335% | |
| 30.8617% | |
| 3.0278% | |
| -49.3767% | |
| -50.201% | |
| -18.3306% | |
| 19.1033% | |
| 104.3189% | |
| 89.5238% | |
| -36.0209% | |
| -53.4271% | |
| -49.9446% | |
| -23.9681% | |
| 89.6723% | |
| 205.9722% | |
| 129.2249% | |
| 84.3792% | |
| 15.4817% | |
| -8.3969% | |
| 6.9293% | |
| 6.6952% | |
| 76.5182% | |
| 71.6157% | |
| 50.2041% | |
| 39.0099% | |
| -13.181% | |
| -32.9429% | |
| -33.6942% | |
| -30.5365% |